The EMPIRIC Institute — which stands for excellence in medicine, patient impact research, innovation and care — was formed to measure and research patient impact within Patient Square Capital’s portfolio companies, according to a July 27 news release.
Dr. Baggett will lead the institute as managing director, in addition to serving as chair and head of patient impact. He also serves on the Baltimore-based Johns Hopkins Bloomberg School of Public Health’s advisory board and as a board member for the Prostate Cancer Foundation.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
